Small-molecule drugs · Domestic sales · Pharmaceutical manufacturing
Celltrion Pharm
Celltrion Group's chemical-drug affiliate handling domestic sales and manufacturing. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
068760.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-09-04'21-51.4%'22-18.8%'23+67.8%'24-45.3%'25+40.6%YTD-44.1%
Money in ▸·
Celltrion Pharm~₩400B
▸ Money out·
Financials & Segments
- Total revenue · ~₩400B (FY2024)
- Segments · Chemical pharmaceuticals · Other
Revenue from
No refined links yet.
Pays to
No refined links yet.